Jennifer King is a Rheumatology/Immunology physician. ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 Veteran Ave
Rehab Center 32-59
Los Angeles, CA 900950001
Telephone
310-825-7992Registry record last updated 7 Nov 2008.
Clinical trials
- Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Sponsor: Indiana University
- A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
Sponsor: Jennifer King
- IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARGENX US, INC.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Aurinia Pharma U.S., Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2005–2022 per NIH RePORTER. The latest:
- The Role of MicroRNA-146a in B Cell Function and Autoimmunity
University of California Los Angeles
FY2022$177,120K08AR072787 - The Role of MicroRNA-146a in B Cell Function and Autoimmunity
University of California Los Angeles
FY2021$177,120K08AR072787 - The Role of MicroRNA-146a in B Cell Function and Autoimmunity
University of California Los Angeles
FY2020$177,120K08AR072787
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”